Mid-Year Report — TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC (2007)

Firm

TEVA PHARMACEUTICALS USA, INC.

Client

TEVA PHARMACEUTICALS USA INC

Income

—

Expenses

$1,100,000

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 1038 - Access to Life-Saving Medicine Act S. 1082 - Food and Drug Administration Revitalization Act S. 1088 - Lower PRICED Drugs Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 1956 - The Patient Protection and Innovative Biologic Medicines Act H.R. 2900 - Food and Drug Administration Amendments Act of 2007 H.R. 3140 - Saving Our Community Pharmacy Act of 2007 H.R. 2606 - 340B Program Improvement and Integrity Act of 2007 S. 25 - Citizen Petition Fairness and Accuracy Act of 2007 S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act]

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	N/A
ASHLEA D THOMAS	N/A

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 1505 (110th), S. 25 (110th), H.R. 2900 (110th), S. 438 (110th), S. 1088 (110th), S. 623 (110th), S. 1082 (110th), H.R. 1956 (110th), H.R. 2606 (110th), H.R. 806 (110th), S. 1695 (110th), H.R. 1038 (110th), H.R. 3140 (110th)

Medicare/Medicaid MMM

H.R. 976 - Children's Health Insurance Program Reauthorization Act of 2007 S. 1893 - Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162 - Children's Health and Medicare Protection Act of 2007

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	N/A
ASHLEA D THOMAS	N/A

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1893 (110th), H.R. 976 (110th), H.R. 3162 (110th)

Budget/Appropriations BUD

President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees Matters relating to FDA Office of Generic Drugs funding

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	N/A
ASHLEA D THOMAS	N/A

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity Matters relating to pharmaceutical provisions in free tree agreements.

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	N/A
ASHLEA D THOMAS	N/A

Contacted: Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

H.R. 1902 - Protecting Consumer Access to Generic Drugs Act H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007

Lobbyist	Covered position, as disclosed
DEBRA BARRETT	N/A
ASHLEA D THOMAS	N/A

Contacted: Food & Drug Administration (FDA); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1145 (110th), H.R. 1902 (110th), H.R. 1432 (110th), S. 316 (110th), H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.